Cancer Research | Penn Today

Genetic mutations in prostate cancer can differ significantly based on race, ethnicity

A study by Kara N. Maxwell of the Perelman School of Medicine finds that prostate cancer tumor biology can differ significantly based on whether a patient is Black or white.

Expert: Antimicrobial resistance is a ‘cancer care crisis’

Yehoda M. Martei of the Perelman School of Medicine says that safely administering cancer treatment fundamentally depends on the availability of antibiotics.

What most American women don’t know when it comes to breast cancer screening

More than half of American women may be confused about when to start regular mammograms to screen for breast cancer, according to a survey from the Annenberg Public Policy Center, with comments by Kathleen Hall Jamieson.

Uterine cancer projected to rise in U.S. by 2050, Black women likely to be hit hardest

Adeiyewunmi (Ade) Osinubi of the Perelman School of Medicine writes about the rise of uterine cancer, especially among African Americans.

The actual chip of human leukemia bone marrow where chambers and channels were filled with food dyes.

Transforming CAR T treatment: ‘Leukemia-on-a-chip’

In a collaborative effort with NYU, Penn researchers have helped pioneer a novel 3D platform that mimics the human bone marrow and immune environment, enabling more predictive testing of cancer immunotherapy success in patients, including CAR T cell therapies.

3 min. read

Food insecurity linked to elevated mortality risk among cancer survivors

A new study from the Perelman School of Medicine shows that cancer survivors experiencing food insecurity had a 28 percent relative increase in risk of death versus those who were food secure.

1 min. read

Philadelphia’s largest cancer centers unite to reduce disparities in prevention and treatment outcomes

A collaborative coalition led by researchers at the Perelman School of Medicine’s Abramson Cancer Center is improving cancer care communication and coordination in Philadelphia by leveraging new community partnerships.

A cutting-edge cancer therapy offers hope for patients with lupus

Discussing CAR T-cell therapy, Carl June of the Perelman School of Medicine asks, “The big question is: How long does it last? Are they cured?”

Penn researchers believe new potential gene therapy for glioblastoma brain cancer offers ‘a lot of hope’

Donald O’Rourke of the Perelman School of Medicine and colleagues have found that a dual-target CAR T cell therapy approach shows promise for slowing tumor growth in glioblastoma, an aggressive and fast-growing brain cancer.

Celebrity breast cancer announcements highlight rising rates in young women

Oluwadamilola Fayanju of the Perelman School of Medicine recommends that young women with breast cancer symptoms go to a center that’s experienced in breast imaging.

Filters